Lord, Abbett & Co. LLC
- SEC CIK
- 0000728100
- Latest filing
- Aug 14, 2026
MRTX holding history
Mirati Therapeutics, Inc. in every 13F filed by Lord, Abbett & Co. LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
MRTX overviewAll 13F holders of MRTXFull Q2 2026 holdings
- Shares (Q4 2022)
- 0
- Sold out in Q4 2022
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 7
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2022 | 0 | $0 | 0.0% | −287,946−100.0% | Sold out | Holders |
| Q3 2022 | 287,946 | $20.1M | 0.1% | −25,349−8.1% | Reduced | Holders |
| Q2 2022 | 313,295 | $21.0M | 0.1% | +5,010+1.6% | Added | Holders |
| Q1 2022 | 308,285 | $25.3M | 0.1% | −189,155−38.0% | Reduced | Holders |
| Q4 2021 | 497,440 | $73.0M | 0.2% | +23,349+4.9% | Added | Holders |
| Q3 2021 | 474,091 | $83.9M | 0.2% | +116,561+32.6% | Added | Holders |
| Q2 2021 | 357,530 | $57.8M | 0.1% | −262,793−42.4% | Reduced | Holders |
| Q1 2021 | 620,323 | $106.3M | 0.3% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.